GE HealthCare announces FDA 510(k) clearance for Aurora, a new dual-head SPECT/CT system, and Clarify DL, its AI-powered Deep Learning image reconstruction technology
United States, May 5 -- GE HealthCare is proud to announce that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of its impressive Aurora nuclear medicine system and Clarify DL. This advanced dual-head SPECT/CT is designed to enhance diagnostic capabilities[i] and streamline workflows, offering clinicians excellent image quality and operational efficiency.As healthcare continues to shift toward precision medicine and personalized care, clinicians require more advanced SPECT/CT solutions that provide greater diagnostic accuracy and efficiency. The ability to monitor and help tailor treatments to individual patients depends on high-quality imaging that can detect subtle disease markers with confidence. To meet these evolvi...
To read the full article or to get the complete feed from this publication, please
Contact Us.